Doctor Byambasuren Ganbaatar
Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima (Japan)
Empagliflozin, a SGLT2 inhibitor, attenuates endothelial dysfunction and atherogenesis by inhibiting inflammatory responses in the vasculature and adipose tissue in diabetic apolipoprotein E-deficient
Event: ESC Congress 2019
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Vascular remodelling from capillaries to aorta
Inhibition of S1P2 receptor ameliorates endothelial dysfunction and prevents atherogenesis in apolipoprotein-E-deficient Mice
Event: ESC Congress 2018
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Vascular disease and endothelium
Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice
Event: ESC Congress 2018
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Inflammation and microcirculation
ESC 365 is supported by
